https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Inclisiran Receives FDA Approval for New Indication to Treat Hypercholesterolemia

Inclisiran Receives FDA Approval for New Indication to Treat Hypercholesterolemia

FDA approves inclisiran as a monotherapy to effectively lower low-density lipoprotein cholesterol in adults with hypercholesterolemia, enhancing heart disease prevention strategies.

administrator

Related Articles